Connable Office Inc Biogen Inc. Transaction History

Connable Office Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 12, 2019	SELL	$278.5 - $352.75 $1.76 Million - $2.23 Million	-6,309 Closed	0 $0
Q3 2018 Nov 06, 2018	SELL	$293.51 - $383.83 $9,685 - $12,666	-33 Reduced 0.52%	6,309 $2.23 Million
Q2 2018 Aug 07, 2018	SELL	$257.52 - $306.91 $3,862 - $4,603	-15 Reduced 0.24%	6,342 $1.84 Million
Q1 2018 May 08, 2018	BUY	$260.13 - $367.91 $24,712 - $34,951	95 Added 1.52%	6,357 $1.74 Million
Q4 2017 Feb 07, 2018	BUY	$307.64 - $344.58 $161,818 - $181,249	526 Added 9.17%	6,262 $2 Million
Q3 2017 Nov 03, 2017	BUY	$281.15 - $329.69 $1.61 Million - $1.89 Million	5,736	5,736 $1.8 Million

1,018

128M

1.22M

1.4M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $25B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Connable Office Inc, based on Form 13F filings with the SEC.

Stay updated on Connable Office Inc with notifications on news.